Table 3.

 Summary of clinicopathological factors and mucin expression in the non-recurrence group (n = 40)

Age (years)	Sex	Site	Size (cm)*	Margin†	Capsular invasion	Tumour variant‡	Mucin expression
							MUC1					MUC2	MUC4	MUC5AC	MUC6
							CORE	DF3	MY.IE12	GP	HMFG-1
49.4 (14.7)	6 M, 34 F	17 parotid, 7 SM, 13 palate, 3 other oral mucosa	2.3 (1.2)	26 +	24 +	14 A	25 −	25 −	18 −	18 −	33 −	38 −	35 −	36 −	26 −
				12 −	16 −	17 B	10 +	12 +	16 +	16 +	7 +	2 +	5 +	4 +	10 +
						9 C	5 ++	3 ++	6 ++	6 ++	0 ++	0 ++	0 ++	0 ++	4 ++

*Maximum diameter; †+, incomplete surgical resection; −, complete surgical resection microscopically; ‡A, stroma rich variant; B, intermediate, C, stroma poor variant.

The positively stained neoplastic cells were graded as follows: −, less than 5% of neoplastic cells stained; +, more than 5% but less than 30% of neoplastic cells stained; ++, more than 30% of neoplastic cells stained.

GP, glycoprotein; SM, submandibular.